Back to Search
Start Over
Significance of delayed primary excision in localized nonmetastatic adult head and neck rhabdomyosarcoma
- Source :
- Cancer Medicine
- Publication Year :
- 2016
-
Abstract
- Adult rhabdomyosarcoma (RMS) is a highly aggressive tumor. Multidisciplinary treatment is important. However, the role of surgery is controversial. The purpose of this study was to reveal the role of a delayed primary excision (DPE) after induction chemotherapy (IC) in localized nonmetastatic adult head and neck RMS. We retrospectively reviewed 24 adult head and neck RMS. Treatment was classified into the following two groups: the DPE group, who received IC followed by surgery, postoperative radiotherapy, and adjuvant chemotherapy (17 patients); the chemoradiotherapy (CRT) group, who received IC followed by chemoradiotherapy (seven patients). We analyzed the efficacy of IC, local control rate (LCR), and overall survival (OS). In the DPE group, 10 patients (59%) underwent complete surgical resection. In the evaluation of the surgical specimens, 14 patients (82%) had residual viable tumors after IC. The response to IC was significantly associated with the 3‐year LCR (CR/PR vs. SD/PD: 100% vs. 33%, P = 0.0014). In patients with good response to chemotherapy, the DPE group had a significantly better 3‐year LCR compared with that of the CRT group (DPE group vs. CRT group, 100% vs. 44%, P = 0.018). However, the treatment modalities were not associated with OS (DPE group vs. CRT group, 65% vs. 57%: P = 0.98). The recurrence patterns differed according to treatments, and distant metastases were more frequent in the DPE group. DPE may impact local control of localized nonmetastatic adult head and neck RMS. Poor response to IC is a risk factor for local recurrence.
- Subjects :
- Adult
Male
Cancer Research
medicine.medical_specialty
medicine.medical_treatment
Postoperative radiotherapy
Urology
Adult rhabdomyosarcoma
Disease-Free Survival
Time-to-Treatment
delayed primary excision
surgery
03 medical and health sciences
Young Adult
0302 clinical medicine
Rhabdomyosarcoma
Medicine
Humans
Radiology, Nuclear Medicine and imaging
Risk factor
Head and neck
Original Research
Chemotherapy
business.industry
Induction chemotherapy
Clinical Cancer Research
Induction Chemotherapy
Middle Aged
medicine.disease
Survival Analysis
Surgery
Treatment Outcome
Oncology
Chemotherapy, Adjuvant
Head and Neck Neoplasms
030220 oncology & carcinogenesis
Female
Radiotherapy, Adjuvant
head and neck sarcoma
business
030217 neurology & neurosurgery
Chemoradiotherapy
Subjects
Details
- ISSN :
- 20457634
- Volume :
- 5
- Issue :
- 10
- Database :
- OpenAIRE
- Journal :
- Cancer medicine
- Accession number :
- edsair.doi.dedup.....290df0e2b8ec12c36f11cb798c41cec8